SNTI
Senti Biosciences Holdings, Inc.
+0.01 (+3.54%)0.32USD204K成交股數10.0M市值–本益比(近四季)182.3股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 17K | 16K | – | – | 0 | 0 | 0-100% | 0-100% | 0 | – | 255K | 687K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 7.8M | 5.3M | 7.8M | 10.5M | 10.0M | 9.3M | 8.7M | 9.2M | 8.8M | – | 9.1M | 6.9M |
| 銷售管理費用 | 6.7M | 6.2M | 5.8M | 6.4M | 6.8M | 7.1M | 6.6M | 4.2M | 7.5M | – | 9.4M | 9.2M |
| 營業利益 | −14.5M-14% | −4.6M-72% | −18.6M+22% | −16.9M+27% | −16.8M+3% | −16.4M | −15.2M-65% | −13.4M-12% | −16.3M | – | −43.9M | −15.2M |
| 營業利益率 | -85,229.4% | -28,850.0% | – | – | – | – | – | – | – | – | -17,206.3% | -2,210.8% |
| 稅後淨利 | −12.8M-13% | −4.2M-70% | −14.5M-50% | −18.1M+62% | −14.7M+22% | −14.1M-80% | −28.9M+93% | −11.2M-40% | −12.1M | −71.1M | −14.9M | −18.7M |
| 淨利率 | -75,000.0% | -26,381.3% | – | – | – | – | – | – | – | – | -5,852.2% | -2,721.5% |
| 稀釋 EPS | -0.41-27% | -0.14-90% | -0.07-99% | -0.69-72% | -0.56-79% | -1.41 | -6.31+88% | -2.45-42% | -2.65 | – | -3.36 | -4.22 |
| 稀釋股數 | 31.1M | 31.0M | 22.5M | 26.2M | 26.1M | 10.0M | 4.6M | 4.6M | 4.6M | – | 4.4M | 4.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 6.5M | 8.9M | 16.4M | 12.2M | 21.6M | 33.8M | 10.5M | 15.9M | 23.7M | 35.9M | 39.4M | 36.8M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | 567K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 33.1M | 38.2M | 51.2M | 52.7M | 68.5M | 82.8M | 57.7M | 86.9M | 102M | 119M | 132M | 144M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 36.5M | 35.7M | 45.6M | 44.6M | 43.9M | 44.9M | 41.7M | 42.8M | 46.1M | 52.6M | 48.8M | 46.2M |
| 股東權益 | −3.4M | 2.6M | 5.6M | 8.1M | 24.7M | 37.9M | 16.0M | 44.1M | 56.1M | 66.9M | 82.9M | 97.4M |
| 負債比 | 110.3% | 93.3% | 89.1% | 84.6% | 64.0% | 54.3% | 72.3% | 49.2% | 45.1% | 44.0% | 37.1% | 32.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −7.5M-47% | – | – | – | −14.1M | – | – | −11.7M | – | – | – |
| 資本支出 | – | – | – | – | – | 0 | – | – | 15K | – | – | – |
| 自由現金流 | – | – | – | – | – | −14.1M | – | – | −11.7M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 22K
| Reportable | 22K | 100.0% | – |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 22K | – | −61.4M | -279,263.6% | -2.73 | −43.6M |
| FY2024 | 0 | -100.0% | −52.8M | –% | -12.03 | −41.4M |
| FY2023 | 2.0M | -39.8% | −71.1M | -3,592.4% | -16.01 | −64.4M |
| FY2022 | 3.3M | +43.4% | −58.2M | -1,771.5% | -2.23 | −76.3M |
| FY2021 | 2.3M | – | −55.3M | -2,414.6% | -19.00 | −40.2M |